Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Outcome Assessment \(Health Care\)"" wg kryterium: Temat


Tytuł :
Rectus femoris transfer in children with cerebral palsy: comparing a propensity score-matched observational study to a randomized controlled trial.
Autorzy :
Schwartz MH; Center for Gait and Motion Analysis, Gillette Children's Specialty Healthcare, St Paul, MN, USA.; Department of Orthopedic Surgery, University of Minnesota, St Paul, MN, USA.
Ries AJ; Center for Gait and Motion Analysis, Gillette Children's Specialty Healthcare, St Paul, MN, USA.
Pokaż więcej
Źródło :
Developmental medicine and child neurology [Dev Med Child Neurol] 2021 Feb; Vol. 63 (2), pp. 196-203. Date of Electronic Publication: 2020 Oct 21.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Data Interpretation, Statistical*
Observational Studies as Topic*/methods
Observational Studies as Topic*/standards
Outcome Assessment, Health Care*/methods
Outcome Assessment, Health Care*/standards
Propensity Score*
Randomized Controlled Trials as Topic*/methods
Randomized Controlled Trials as Topic*/standards
Cerebral Palsy/*rehabilitation
Gait Disorders, Neurologic/*surgery
Knee/*surgery
Adolescent ; Cerebral Palsy/complications ; Child ; Child, Preschool ; Cohort Studies ; Databases, Factual ; Female ; Gait Disorders, Neurologic/etiology ; Gait Disorders, Neurologic/physiopathology ; Humans ; Knee/physiopathology ; Male ; Quadriceps Muscle ; Surgical Procedures, Operative
Czasopismo naukowe
Tytuł :
Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in California.
Autorzy :
Herring AA; Department of Emergency Medicine and Internal Medicine, Highland Hospital-Alameda Health System, Oakland, CA, United States of America; California Bridge Program, Public Health Institute, United States of America; University of California, San Francisco, San Francisco, CA, United States of America. Electronic address: .
Kalmin M; Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America.
Speener M; Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, CA, United States of America.
Goodman-Meza D; Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America; Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, CA, United States of America.
Snyder H; Department of Family and Community Medicine, University of California, San Francisco, San Francisco, CA, United States of America; California Bridge Program, Public Health Institute, United States of America.
Campbell A; California Bridge Program, Public Health Institute, United States of America; Department of Emergency Medicine, Marshall Medical Center, Placerville, CA, United States of America.
Moulin A; California Bridge Program, Public Health Institute, United States of America; Department of Emergency Medicine and Psychiatry, UC Davis Medical Center, Sacramento, CA, United States of America.
Shoptaw S; Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America.
Pokaż więcej
Źródło :
Journal of substance abuse treatment [J Subst Abuse Treat] 2021 Apr; Vol. 123, pp. 108260. Date of Electronic Publication: 2020 Dec 27.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
COVID-19*
Outcome Assessment, Health Care*
Practice Patterns, Physicians'*
SARS-CoV-2*
Buprenorphine/*therapeutic use
Emergency Service, Hospital/*statistics & numerical data
Narcotic Antagonists/*therapeutic use
Opioid-Related Disorders/*drug therapy
Buprenorphine/administration & dosage ; California ; Humans ; Narcotic Antagonists/administration & dosage
Czasopismo naukowe
Tytuł :
Professional patient navigation in a hospital setting: a randomized controlled trial.
Autorzy :
Berezowska A; Center for Quality of Life, Netherlands Cancer Institute, Mailbox 90203, 1006 BE, Amsterdam, Netherlands.; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Mailbox 90203, 1006 BE, Amsterdam, Netherlands.
Passchier E; Center for Quality of Life, Netherlands Cancer Institute, Mailbox 90203, 1006 BE, Amsterdam, Netherlands.
Bleiker E; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Mailbox 90203, 1006 BE, Amsterdam, Netherlands. .
Pokaż więcej
Źródło :
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2021 Apr; Vol. 29 (4), pp. 2111-2123. Date of Electronic Publication: 2020 Aug 31.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Outcome Assessment, Health Care*
Patient Navigation/*methods
Quality of Life/*psychology
Aged ; Female ; Humans ; Male ; Middle Aged ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
The effectiveness of public health interventions against COVID-19: Lessons from the Singapore experience.
Autorzy :
Ansah JP; Programme in Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.; Residential College 4, National University of Singapore, Singapore, Singapore.
Matchar DB; Programme in Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.; Department of Internal Medicine (General Internal Medicine), Duke University, Singapore, Singapore.; Department of Internal Medicine, Singapore General Hospital, Singapore, Singapore.
Shao Wei SL; Programme in Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.; Health Services Research Centre, Singapore Health Services, Singapore, Singapore.
Low JG; Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
Pourghaderi AR; Programme in Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.; Health Services Research Centre, Singapore Health Services, Singapore, Singapore.
Siddiqui FJ; Programme in Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.
Min TLS; Programme in Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.
Wei-Yan AC; Programme in Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.
Ong MEH; Programme in Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.; Department of Emergency Medicine, Singapore General Hospital, Singapore, Singapore.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2021 Mar 30; Vol. 16 (3), pp. e0248742. Date of Electronic Publication: 2021 Mar 30 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Outcome Assessment, Health Care*
Public Health*
COVID-19/*epidemiology
COVID-19/prevention & control ; Contact Tracing ; Humans ; Models, Statistical ; Quarantine ; Singapore/epidemiology
Czasopismo naukowe
Tytuł :
Strategy to reduce adverse health outcomes in subjects highly vulnerable to COVID-19: results from a population-based study in Northern Italy.
Autorzy :
Russo AG; Epidemiology Unit, Agency for Health Protection of the Metropolitan Area of Milan, Milano, Italy .
Faccini M; Infectious Diseases Unit, Prevention Department, Agency for Health Protection of the Metropolitan Area of Milan, Milano, Italy.
Bergamaschi W; General Directorate, Agency for Health Protection of the Metropolitan Area of Milan, Milano, Italy.
Riussi A; Epidemiology Unit, Agency for Health Protection of the Metropolitan Area of Milan, Milano, Italy.
Pokaż więcej
Źródło :
BMJ open [BMJ Open] 2021 Mar 10; Vol. 11 (3), pp. e046044. Date of Electronic Publication: 2021 Mar 10.
Typ publikacji :
Journal Article
MeSH Terms :
Health Status*
Outcome Assessment, Health Care*
COVID-19/*mortality
Aged ; Hospitalization ; Humans ; Italy/epidemiology ; Morbidity ; Mortality ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Treatment effects in randomised trials using routinely collected data for outcome assessment versus traditional trials: meta-research study.
Autorzy :
Mc Cord KA; Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.
Ewald H; Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.; University Medical Library, University of Basel, Basel, Switzerland.
Agarwal A; Department of Medicine, University of Toronto, Toronto, ON, Canada.
Glinz D; Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.
Aghlmandi S; Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.
Ioannidis JPA; Stanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Meta-Research Innovation Center Berlin (METRIC-B), Berlin Institute of Health, Berlin, Germany.
Hemkens LG; Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel, University of Basel, 4031 Basel, Switzerland .; Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Palo Alto, CA, USA.; Meta-Research Innovation Center Berlin (METRIC-B), Berlin Institute of Health, Berlin, Germany.
Pokaż więcej
Źródło :
BMJ (Clinical research ed.) [BMJ] 2021 Mar 03; Vol. 372, pp. n450. Date of Electronic Publication: 2021 Mar 03.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Outcome Assessment, Health Care*
Randomized Controlled Trials as Topic*
Routinely Collected Health Data*
Humans
Czasopismo naukowe
Tytuł :
A Patient-Centric Tool to Facilitate Goal Attainment Scaling in Neurogenic Bladder and Bowel Dysfunction: Path to Individualization.
Autorzy :
Goldstine J; Hollister Incorporated, Libertyville, IL, USA.
Knox K; DGI Clinical Inc, Halifax, NS, Canada.
Beekman J; Sint Maartenskliniek, Nijmegen, The Netherlands.
Cobussen-Boekhorst H; Radboud University Medical Center, Nijmegen, The Netherlands.
Conti A; University of Torino, Turin, Italy.
Gray M; University of Virginia, Charlottesville, VA, USA.
Inglese G; Hollister Incorporated, Libertyville, IL, USA.
England A; DGI Clinical Inc, Halifax, NS, Canada.
Rodriguez G; Michigan Medicine, Ann Arbor, MI, USA.
Stanley J; DGI Clinical Inc, Halifax, NS, Canada. Electronic address: .
Vaughn S; California State University, Fullerton, CA, USA.
Howlett SE; DGI Clinical Inc, Halifax, NS, Canada; Division of Geriatric Medicine, Dalhousie University, Halifax, NS, Canada; Department of Pharmacology, Dalhousie University, Halifax, NS, Canada.
Rockwood K; DGI Clinical Inc, Halifax, NS, Canada; Division of Geriatric Medicine, Dalhousie University, Halifax, NS, Canada.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Mar; Vol. 24 (3), pp. 413-420. Date of Electronic Publication: 2021 Jan 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Patient Care Planning*
Constipation/*psychology
Diarrhea/*psychology
Outcome Assessment, Health Care/*methods
Urinary Bladder, Neurogenic/*psychology
Adult ; Female ; Humans ; Male ; Middle Aged ; Outcome Assessment, Health Care/standards ; Surveys and Questionnaires/standards
Czasopismo naukowe
Tytuł :
Evidence-Based and Clinically Relevant Outcomes for Hemorrhage Control Trauma Trials.
Autorzy :
Holcomb JB; Center for Injury Science, Division of Acute Care Surgery, University of Alabama at Birmingham, Birmingham, AL.
Moore EE; Ernest E. Moore Shock Trauma Center at Denver Health, Distinguished Professor, Ernest E Moore Shock Trauma Center at Denver Health, University of Colorado Denver, Denver, CO.
Sperry JL; Pittsburgh Trauma Research Center and the Department of Surgery, University of Pittsburgh, Pittsburgh, PA.
Jansen JO; Division of Acute Care Surgery, Center for Injury Science, University of Alabama at Birmingham, Birmingham, AL.
Schreiber MA; Oregon Health & Science University, Portland, OR.
Del Junco DJ; Joint Trauma System, DoD Center of Excellence for Trauma, San Antonio, TX.
Spinella PC; Division of Critical Care, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Sauaia A; Department of Public Health and Surgery, University of Colorado Denver, School of Public health, University of Colorado, Denver, CO.
Brohi K; Centre for Trauma Sciences, Queen Mary University of London, London, UK.
Bulger EM; Department of Surgery, University of Washington, Seattle WA.
Cap AP; US Army Institute of Surgical Research, Uniformed Services University, Ft Sam Houston, TX.
Hess JR; Department of Laboratory Medicine and Hematology, University of Washington School of Medicine, Seattle, WA.
Jenkins D; Department of Surgery, Division of Trauma and Emergency Surgery, UT Health, San Antonio, TX.
Lewis RJ; Berry Consultants LLC, Austin, TX; Department of Emergency Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Neal MD; Pittsburgh Trauma Research Center and the Department of Surgery, University of Pittsburgh, Pittsburgh, PA.
Newgard C; Center for Policy and Research in Emergency Medicine, Oregon Health & Science University, Portland, OR.
Pati S; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA.
Pusateri AE; US Army Institute of Surgical Research, JBSA-Fort Sam Houston, San Antonio, TX.
Rizoli S; Department of Surgery, Hamad General Hospital, Doha, Qatar.
Russell RT; Children's Hospital of Alabama, University of Alabama at Birmingham, Birmingham, AL.
Shackelford SA; Joint Trauma System, Defense Health Agency, San Antonio, TX.
Stein DM; Zuckerberg San Francisco General Hospital and Trauma Center, UCSF, San Francisco, CA.
Steiner ME; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Division of Pediatric Critical Care Medicine, University of Minnesota Medical School, Minneapolis, MN.
Wang H; Department of Emergency Medicine, University of Texas Health Science Center at Houston, Houston TX.
Ward KR; Emergency Medicine and Biomedical Engineering, Executive Director, Michigan Center for Integrative Research in Critical Care, University of Michigan, Ann Arbor, MI.
Young P; American Red Cross, Biomedical Division, Washington, D.C., Vanderbilt University Medical Center, Nashville, TN.
Pokaż więcej
Źródło :
Annals of surgery [Ann Surg] 2021 Mar 01; Vol. 273 (3), pp. 395-401.
Typ publikacji :
Journal Article
MeSH Terms :
Clinical Trials as Topic*
Outcome Assessment, Health Care*
Hemostasis, Surgical/*methods
Shock, Hemorrhagic/*etiology
Shock, Hemorrhagic/*prevention & control
Consensus ; Evidence-Based Medicine ; Hemostatics/therapeutic use ; Humans ; Patient-Centered Care ; Shock, Hemorrhagic/mortality
Czasopismo naukowe
Tytuł :
Rehabilitation Treatment Specification System: Methodology to Identify and Describe Unique Targets and Ingredients.
Autorzy :
Van Stan JH; Harvard Medical School, Boston, Massachusetts; Massachusetts General Hospital Center for Laryngeal Surgery and Voice Rehabilitation, Boston, Massachusetts; MGH Institute of Health Professions, Charlestown, Massachusetts. Electronic address: .
Whyte J; Moss Rehabilitation Research Institute, Elkins Park, Pennsylvania.
Duffy JR; Mayo Clinic, Rochester, Minnesota.
Barkmeier-Kraemer JM; University of Utah, Salt Lake City, Utah.
Doyle PB; University of Connecticut Medical School, Farmington, Connecticut.
Gherson S; New York University, New York, New York.
Kelchner L; University of Cincinnati, Cincinnati, Ohio.
Muise J; Harvard Medical School, Boston, Massachusetts; Massachusetts General Hospital Center for Laryngeal Surgery and Voice Rehabilitation, Boston, Massachusetts; MGH Institute of Health Professions, Charlestown, Massachusetts.
Petty B; Emory University, Atlanta, Georgia.
Roy N; University of Utah, Salt Lake City, Utah.
Stemple J; University of Kentucky, Lexington, Kentucky.
Thibeault S; University of Wisconsin, Madison, Wisconsin.
Tolejano CJ; University of Wisconsin, Madison, Wisconsin.
Pokaż więcej
Źródło :
Archives of physical medicine and rehabilitation [Arch Phys Med Rehabil] 2021 Mar; Vol. 102 (3), pp. 521-531. Date of Electronic Publication: 2020 Oct 13.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Clinical Decision-Making*
Outcome Assessment, Health Care*
Clinical Protocols/*standards
Patient Care Planning/*standards
Rehabilitation/*standards
Delphi Technique ; Humans ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
SARS-CoV-2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California.
Autorzy :
Anantharaman A; Department of Hematology and Oncology, Kaiser Permanente Northern California, California, USA.
Dusendang JR; Division of Research, Kaiser Permanente Northern California, California, USA.
Schmittdiel JA; Division of Research, Kaiser Permanente Northern California, California, USA.
Harzstark AL; Department of Urology, Kaiser Permanente Northern California, Sacramento, California, USA.
Pokaż więcej
Źródło :
The oncologist [Oncologist] 2021 Mar; Vol. 26 (3), pp. e500-e504. Date of Electronic Publication: 2020 Dec 03.
Typ publikacji :
Journal Article
MeSH Terms :
Outcome Assessment, Health Care*
COVID-19/*complications
Neoplasms/*complications
Neoplasms/*immunology
Pneumonia, Viral/*complications
Adolescent ; Adult ; Aged ; COVID-19/epidemiology ; California/epidemiology ; Female ; Humans ; Immunocompromised Host ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/virology ; Retrospective Studies ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Clinical Characteristics and Outcomes of 821 Older Patients With SARS-Cov-2 Infection Admitted to Acute Care Geriatric Wards.
Autorzy :
Zerah L; Assistance Publique-Hôpitaux de Paris (APHP), Hôpital La Pitié-Salpêtrière, Department of Geriatric Medicine, France.; Sorbonne Université, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris, France.
Baudouin É; Assistance Publique-Hôpitaux de Paris (APHP), Hôpital La Pitié-Salpêtrière, Department of Geriatric Medicine, France.
Pépin M; APHP, Hôpital Ambroise Paré, Department of Geriatric Medicine, Boulogne, Billancourt, France.; Université de Versailles Saint-Quentin en Yvelynes, Université Paris-Saclay, INSERM, CESP, Villejuif, France.
Mary M; APHP, Hôpital Paul Brousse, Department of Geriatric Medicine, Villejuif, France.
Krypciak S; APHP, Hôpital Henri Mondor, Department of Geriatric Medicine, Créteil, France.; Université Paris Est Creteil, INSERM, IMRB, France.
Bianco C; APHP, Hôpital Saint Antoine, Department of Geriatric Medicine, Paris, France.; Sorbonne Université, INSERM, UMRS 1135, Centre d'immunologie et de Maladies Infectieuses (CIMI), Paris, France.
Roux S; APHP, Hôpital Corentin Celton, Department of Geriatric Medicine, Issy les Moulineaux, France.
Gross A; APHP, Université de Paris, Hôpital Bichat, Department of Geriatric Medicine, France.
Toméo C; Assistance Publique-Hôpitaux de Paris (APHP), Hôpital La Pitié-Salpêtrière, Department of Geriatric Medicine, France.
Lemarié N; APHP, Sorbonne Université, Hôpital Tenon, Department of Geriatric Medicine, Paris, France.
Dureau A; APHP, Sorbonne Université, Hôpital Rothschild, Department of Geriatric Medicine, Paris, France.
Bastiani S; APHP, Université Paris Sud, Hôpital Béclère, Department of Geriatric Medicine, Clamart, France.
Ketz F; APHP, Sorbonne Université, Hôpital Charles Foix, Department of Geriatric Medicine, Ivry sur Seine, France.
Boully C; APHP, Hôpital Broca, Department of Geriatric Medicine, Paris, France.; Université de Paris, Sorbonne Paris-Cité, Team, France.
de Villelongue C; APHP, Université de Paris, Hôpital Bretonneau, Department of Geriatric Medicine and Palliative Care, France.
Romdhani M; APHP, Université de Paris, Hôpital Bretonneau, Department of Psychogeriatric Medicine, France.
Desoutter MA; APHP, Hôpital Ambroise Paré, Department of Geriatric Medicine, Boulogne, Billancourt, France.; Université de Versailles Saint-Quentin en Yvelynes, Université Paris-Saclay, INSERM, CESP, Villejuif, France.
Duron E; APHP, Hôpital Paul Brousse, Department of Geriatric Medicine, Villejuif, France.; Université Paris-Saclay, INSERM 1178, CESP, Équipe MOODS. Le Kremlin-Bicêtre, France.
David JP; APHP, Hôpital Henri Mondor, Department of Geriatric Medicine, Créteil, France.; Université Paris Est Creteil, INSERM, IMRB, France.
Thomas C; APHP, Hôpital Saint Antoine, Department of Geriatric Medicine, Paris, France.
Paillaud E; Université Paris Est Creteil, INSERM, IMRB, France.; APHP, Paris Cancer Institute CARPEM, Department of Geriatric Medicine, Hôpital Européen Georges Pompidou, France.
de Malglaive P; APHP, Université de Paris, Hôpital Bichat, Department of Geriatric Medicine, France.
Bouvard E; APHP, Sorbonne Université, Hôpital Tenon, Department of Geriatric Medicine, Paris, France.
Lacrampe M; APHP, Sorbonne Université, Hôpital Rothschild, Department of Geriatric Medicine, Paris, France.
Mercadier E; APHP, Université Paris Sud, Hôpital Béclère, Department of Geriatric Medicine, Clamart, France.
Monti A; APHP, Sorbonne Université, Hôpital Charles Foix, Department of Geriatric Medicine, Ivry sur Seine, France.
Hanon O; APHP, Hôpital Broca, Department of Geriatric Medicine, Paris, France.; Université de Paris, Sorbonne Paris-Cité, Team, France.
Fossey-Diaz V; APHP, Université de Paris, Hôpital Bretonneau, Department of Geriatric Medicine and Palliative Care, France.
Bourdonnec L; APHP, Université de Paris, Hôpital Bretonneau, Department of Psychogeriatric Medicine, France.
Riou B; Sorbonne Université, UMRS INSERM 1166, Paris, France.; APHP, Hôpital La Pitié-Salpêtrière, Department of Emergency Medicine, Paris, France.
Vallet H; APHP, Hôpital Saint Antoine, Department of Geriatric Medicine, Paris, France.; Sorbonne Université, INSERM, UMRS 1135, Centre d'immunologie et de Maladies Infectieuses (CIMI), Paris, France.
Boddaert J; Assistance Publique-Hôpitaux de Paris (APHP), Hôpital La Pitié-Salpêtrière, Department of Geriatric Medicine, France.; Sorbonne Université, INSERM, UMRS 1135, Centre d'immunologie et de Maladies Infectieuses (CIMI), Paris, France.
Pokaż więcej
Źródło :
The journals of gerontology. Series A, Biological sciences and medical sciences [J Gerontol A Biol Sci Med Sci] 2021 Feb 25; Vol. 76 (3), pp. e4-e12.
Typ publikacji :
Journal Article
MeSH Terms :
Geriatric Assessment*
Hospitalization*
Outcome Assessment, Health Care*
COVID-19/*therapy
Pneumonia, Viral/*therapy
Aged ; Aged, 80 and over ; COVID-19/epidemiology ; COVID-19/mortality ; Female ; Hospital Mortality ; Humans ; Male ; Pandemics ; Paris/epidemiology ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/mortality ; Pneumonia, Viral/virology ; Retrospective Studies ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis: A Phase 2 Randomized Control Trial.
Autorzy :
Bril V; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium. .
Benatar M; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Andersen H; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Vissing J; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Brock M; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Greve B; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Kiessling P; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Woltering F; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Griffin L; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Van den Bergh P; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Pokaż więcej
Corporate Authors :
MG0002 Investigators
Źródło :
Neurology [Neurology] 2021 Feb 09; Vol. 96 (6), pp. e853-e865. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Outcome Assessment, Health Care*
Antibodies, Monoclonal, Humanized/*pharmacology
Immunosuppressive Agents/*pharmacology
Myasthenia Gravis/*drug therapy
Adult ; Aged ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/adverse effects ; Double-Blind Method ; Female ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Autologous Hematopoietic Stem Cell Transplantation for Stiff-Person Spectrum Disorder: A Clinical Trial.
Autorzy :
Burt RK; From the Division of Immunotherapy (R.K.B., X.H., K.Q., I.A.), Department of Medicine, Department of Neurology (R.B., T.S.), Department of Preventive Medicine (I.H.), and Department of Pathology and Cell and Developmental Biology (T.S.), Northwestern University, Chicago, IL; and Department of Neurology (J.R.), University of Utah, Salt Lake City.
Balabanov R; From the Division of Immunotherapy (R.K.B., X.H., K.Q., I.A.), Department of Medicine, Department of Neurology (R.B., T.S.), Department of Preventive Medicine (I.H.), and Department of Pathology and Cell and Developmental Biology (T.S.), Northwestern University, Chicago, IL; and Department of Neurology (J.R.), University of Utah, Salt Lake City.
Han X; From the Division of Immunotherapy (R.K.B., X.H., K.Q., I.A.), Department of Medicine, Department of Neurology (R.B., T.S.), Department of Preventive Medicine (I.H.), and Department of Pathology and Cell and Developmental Biology (T.S.), Northwestern University, Chicago, IL; and Department of Neurology (J.R.), University of Utah, Salt Lake City.
Quigley K; From the Division of Immunotherapy (R.K.B., X.H., K.Q., I.A.), Department of Medicine, Department of Neurology (R.B., T.S.), Department of Preventive Medicine (I.H.), and Department of Pathology and Cell and Developmental Biology (T.S.), Northwestern University, Chicago, IL; and Department of Neurology (J.R.), University of Utah, Salt Lake City.
Arnautovic I; From the Division of Immunotherapy (R.K.B., X.H., K.Q., I.A.), Department of Medicine, Department of Neurology (R.B., T.S.), Department of Preventive Medicine (I.H.), and Department of Pathology and Cell and Developmental Biology (T.S.), Northwestern University, Chicago, IL; and Department of Neurology (J.R.), University of Utah, Salt Lake City.
Helenowski I; From the Division of Immunotherapy (R.K.B., X.H., K.Q., I.A.), Department of Medicine, Department of Neurology (R.B., T.S.), Department of Preventive Medicine (I.H.), and Department of Pathology and Cell and Developmental Biology (T.S.), Northwestern University, Chicago, IL; and Department of Neurology (J.R.), University of Utah, Salt Lake City.
Rose J; From the Division of Immunotherapy (R.K.B., X.H., K.Q., I.A.), Department of Medicine, Department of Neurology (R.B., T.S.), Department of Preventive Medicine (I.H.), and Department of Pathology and Cell and Developmental Biology (T.S.), Northwestern University, Chicago, IL; and Department of Neurology (J.R.), University of Utah, Salt Lake City.
Siddique T; From the Division of Immunotherapy (R.K.B., X.H., K.Q., I.A.), Department of Medicine, Department of Neurology (R.B., T.S.), Department of Preventive Medicine (I.H.), and Department of Pathology and Cell and Developmental Biology (T.S.), Northwestern University, Chicago, IL; and Department of Neurology (J.R.), University of Utah, Salt Lake City.
Pokaż więcej
Źródło :
Neurology [Neurology] 2021 Feb 09; Vol. 96 (6), pp. e817-e830. Date of Electronic Publication: 2020 Dec 14.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*/adverse effects
Outcome Assessment, Health Care*
Immunosuppressive Agents/*administration & dosage
Stiff-Person Syndrome/*physiopathology
Stiff-Person Syndrome/*therapy
Adult ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Stiff-Person Syndrome/drug therapy ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Multidimensional Prognostic Index (MPI) score has the major impact on outcome prediction in elderly surgical patients with colorectal cancer: The FRAGIS study.
Autorzy :
Pata G; General Surgery 2 Unit, University Hospital ASST Spedali Civili of Brescia, Brescia, Italy.
Bianchetti L; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Rota M; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Marengoni A; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Chiesa D; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Cassinotti E; Department of Surgery, Fondazione IRCCS-Ca' Granda-Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Palmisano S; Department of Surgery, Ospedali Riuniti, University of Trieste, Trieste, Italy.
Colombi M; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Del Zotto G; Department of Surgery, Ospedali Riuniti, University of Trieste, Trieste, Italy.
Romanelli G; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Calza S; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.; Big and Open Data Innovation Laboratory (BODaI-Lab), University of Brescia, Brescia, Italy.
Boni L; Department of Surgery, Fondazione IRCCS-Ca' Granda-Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
De Manzini N; Department of Surgery, Ospedali Riuniti, University of Trieste, Trieste, Italy.
Fumagalli Romario U; General Surgery 2 Unit, University Hospital ASST Spedali Civili of Brescia, Brescia, Italy.; Digestive Surgery Unit, European Institute of Oncology (IEO), IRCCS, Milan, Italy.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2021 Feb; Vol. 123 (2), pp. 667-675. Date of Electronic Publication: 2020 Nov 25.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Outcome Assessment, Health Care*
Patient Selection*
Colorectal Neoplasms/*mortality
Elective Surgical Procedures/*mortality
Geriatric Assessment/*methods
Postoperative Complications/*mortality
Risk Assessment/*methods
Aged ; Aged, 80 and over ; Colorectal Neoplasms/pathology ; Colorectal Neoplasms/surgery ; Female ; Follow-Up Studies ; Humans ; Male ; Prognosis ; Prospective Studies ; Risk Factors ; Survival Rate
Czasopismo naukowe
Tytuł :
Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome.
Autorzy :
Lee RJ; The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK. Electronic address: .
Wysocki O; The University of Manchester, Manchester, UK; Digital Experimental Cancer Medicine Team, Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park, UK.
Bhogal T; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; The University of Liverpool, Liverpool, UK.
Shotton R; The Christie NHS Foundation Trust, Manchester, UK.
Tivey A; The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK.
Angelakas A; University Hospitals of Morecambe Bay, Kendal, UK.
Aung T; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
Banfill K; The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK.
Baxter M; University of Dundee, Dundee, UK.
Boyce H; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
Brearton G; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.
Copson E; Cancer Sciences Academic Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Dickens E; Leicester Cancer Research Centre, University of Leicester, Leicester, UK.
Eastlake L; University Hospitals Plymouth NHS Trust, Plymouth, UK.
Gomes F; The Christie NHS Foundation Trust, Manchester, UK.
Hague C; The Christie NHS Foundation Trust, Manchester, UK.
Harrison M; Ninewells Hospital, Dundee, UK.
Horsley L; The Christie NHS Foundation Trust, Manchester, UK.
Huddar P; Lancashire Teaching Hospitals NHS Trust, Preston, UK.
Hudson Z; Bristol Haematology and Oncology Centre, Bristol, UK.
Khan S; Leicester Cancer Research Centre, University of Leicester, Leicester, UK; Oncology Department, University Hospitals of Leicester NHS Trust, Leicester, UK.
Khan UT; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; The University of Liverpool, Liverpool, UK.
Maynard A; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
McKenzie H; Cancer Sciences Academic Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Palmer D; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; The University of Liverpool, Liverpool, UK.
Robinson T; Bristol Haematology and Oncology Centre, Bristol, UK; Sunrise Oncology Centre, Royal Cornwall Hospital, Truro, UK.
Rowe M; National Institute for Biological Standards and Control, Potters Bar, UK.
Thomas A; Leicester Cancer Research Centre, University of Leicester, Leicester, UK; Oncology Department, University Hospitals of Leicester NHS Trust, Leicester, UK.
Tweedy J; Institute of Infection and Global Health, University of Liverpool and Tropical and Infectious Diseases Unit, Royal Liverpool Hospital, Liverpool, UK.
Sheehan R; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
Stockdale A; Cancer Research UK Manchester Institute, Cancer Biomarker Centre, The University of Manchester, Alderley Park, UK.
Weaver J; The Christie NHS Foundation Trust, Manchester, UK.
Williams S; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
Wilson C; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
Zhou C; The University of Bristol, Bristol, UK.
Dive C; The University of Bristol, Bristol, UK.
Cooksley T; The Christie NHS Foundation Trust, Manchester, UK.
Palmieri C; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; The University of Liverpool, Liverpool, UK.
Freitas A; The University of Manchester, Manchester, UK; Digital Experimental Cancer Medicine Team, Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park, UK.
Armstrong AC; The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK.
Pokaż więcej
Źródło :
ESMO open [ESMO Open] 2021 Feb; Vol. 6 (1), pp. 100005. Date of Electronic Publication: 2020 Nov 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19/*prevention & control
Neoplasms/*therapy
Outcome Assessment, Health Care/*statistics & numerical data
SARS-CoV-2/*isolation & purification
Adult ; Aged ; Aged, 80 and over ; C-Reactive Protein/analysis ; COVID-19/virology ; Female ; Humans ; L-Lactate Dehydrogenase/metabolism ; Logistic Models ; Longitudinal Studies ; Lymphocyte Count ; Lymphocytes/metabolism ; Male ; Middle Aged ; Neoplasms/blood ; Neoplasms/metabolism ; Neutrophils/metabolism ; Outcome Assessment, Health Care/methods ; Platelet Count ; SARS-CoV-2/physiology ; United Kingdom ; Young Adult
Czasopismo naukowe
Tytuł :
Does Duration of Pain at Baseline Influence Longer-term Clinical Outcomes of Low Back Pain Patients Managed on an Evidence-Based Pathway?
Autorzy :
Jess MA; School of Health and Life Sciences, Teesside University, Middlesbrough, UK.
Ryan C; School of Health and Life Sciences, Teesside University, Middlesbrough, UK.
Hamilton S; School of Health and Life Sciences, Teesside University, Middlesbrough, UK.
Wellburn S; School of Health and Life Sciences, Teesside University, Middlesbrough, UK.
Atkinson G; School of Health and Life Sciences, Teesside University, Middlesbrough, UK.
Greenough C; South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK.
Peat G; South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK.
Coxon A; South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK.
Fatoye F; Department of Health Professions, Faculty of Health Psychology and Social Care, Manchester Metropolitan University, Manchester, UK.
Ferguson D; Northumbria Healthcare NHS Trust, North Tyneside General Hospital, North Shields, UK.; Primary Care Rheumatology & Musculoskeletal Medicine (PCRMM) Society, York, North Yorkshire, UK.
Dickson A; Primary Care Rheumatology & Musculoskeletal Medicine (PCRMM) Society, York, North Yorkshire, UK.; GP Lead for the North of England Back and Radicular Pain Pathway, UK.
Ridley H; Getting It Right First Time (GIRFT): Clinically-led improvement programme delivered in partnership with the Royal National Orthopedic Hospitals NHS Trust, NHS England and NHS Improvement, UK.
Martin D; School of Health and Life Sciences, Teesside University, Middlesbrough, UK.
Pokaż więcej
Źródło :
Spine [Spine (Phila Pa 1976)] 2021 Feb 01; Vol. 46 (3), pp. 191-197.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Outcome Assessment, Health Care*
Low Back Pain/*complications
England ; Female ; Humans ; Longitudinal Studies ; Low Back Pain/epidemiology ; Male ; Quality of Life ; Surveys and Questionnaires ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Association of Mandatory Bundled Payments for Joint Replacement With Postacute Care Outcomes Among Medicare and Medicaid Dual Eligible Patients.
Autorzy :
Li Y; Departments of Public Health Sciences, Division of Health Policy and Outcomes Research.
Ying M; Departments of Public Health Sciences, Division of Health Policy and Outcomes Research.
Cai X; Biostatistics and Computational Biology.
Thirukumaran CP; Departments of Public Health Sciences, Division of Health Policy and Outcomes Research.; Orthopaedics, University of Rochester Medical Center, Rochester, NY.
Pokaż więcej
Źródło :
Medical care [Med Care] 2021 Feb 01; Vol. 59 (2), pp. 101-110.
Typ publikacji :
Journal Article; Observational Study; Research Support, N.I.H., Extramural
MeSH Terms :
Arthroplasty, Replacement/*economics
Medicaid/*statistics & numerical data
Medicare/*statistics & numerical data
Outcome Assessment, Health Care/*standards
Arthroplasty, Replacement/methods ; Cohort Studies ; Eligibility Determination/statistics & numerical data ; Humans ; Medicaid/organization & administration ; Medicare/organization & administration ; Outcome Assessment, Health Care/statistics & numerical data ; Postoperative Care/economics ; Postoperative Care/standards ; Postoperative Care/statistics & numerical data ; Quality of Health Care/economics ; Quality of Health Care/standards ; Quality of Health Care/statistics & numerical data ; Reimbursement Mechanisms/standards ; Reimbursement Mechanisms/statistics & numerical data ; Subacute Care/economics ; Subacute Care/standards ; Subacute Care/statistics & numerical data ; United States
Czasopismo naukowe
Tytuł :
Leisure-time physical activity interventions for children and adults with cerebral palsy: a scoping review.
Autorzy :
Lai B; Division of Pediatric Rehabilitation Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Lee E; The Rehabilitation Science Program, School of Health Professions, University of Alabama at Birmingham, Birmingham, AL, USA.
Kim Y; The Rehabilitation Science Program, School of Health Professions, University of Alabama at Birmingham, Birmingham, AL, USA.
Matthews C; Department of Mechanical and Aerospace Engineering, University of Virginia, Charlottesville, VI, USA.
Swanson-Kimani E; Division of Pediatric Rehabilitation Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Davis D; Division of Pediatric Rehabilitation Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Vogtle L; Department of Occupational Therapy, School of Health Professions, University of Alabama at Birmingham, Birmingham, AL, USA.
Rimmer JH; School of Health Professions, Dean's Office, University of Alabama at Birmingham, Birmingham, AL, USA.
Pokaż więcej
Źródło :
Developmental medicine and child neurology [Dev Med Child Neurol] 2021 Feb; Vol. 63 (2), pp. 162-171. Date of Electronic Publication: 2020 Nov 25.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Exercise Therapy*/methods
Neurological Rehabilitation*/methods
Outcome Assessment, Health Care*
Recreation*
Cerebral Palsy/*rehabilitation
Adolescent ; Adult ; Child ; Child, Preschool ; Female ; Humans ; Male ; Randomized Controlled Trials as Topic ; Young Adult
Czasopismo naukowe
Tytuł :
Systematic reviews: a brief overview.
Autorzy :
Calo NC; Methods in Epidemiologic, Clinical, and Operations Research-MECOR-program, American Thoracic Society/Asociación Latinoamericana del Tórax, Montevideo, Uruguay.; Department of Medicine, Division of Gastroenterology, University of Ottawa, Ottawa, ON, Canada.
Ferreira JC; Methods in Epidemiologic, Clinical, and Operations Research-MECOR-program, American Thoracic Society/Asociación Latinoamericana del Tórax, Montevideo, Uruguay.; Divisão de Pneumologia, Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo (SP) Brasil.
Patino CM; Methods in Epidemiologic, Clinical, and Operations Research-MECOR-program, American Thoracic Society/Asociación Latinoamericana del Tórax, Montevideo, Uruguay.; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Pokaż więcej
Źródło :
Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia [J Bras Pneumol] 2020 Nov 02; Vol. 46 (5), pp. e20200475. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji :
Journal Article
MeSH Terms :
Outcome Assessment, Health Care*/methods
Outcome Assessment, Health Care*/standards
Systematic Reviews as Topic*
Humans ; Research Design
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies